bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 84,000 shares, an increase of 7.4% from the June 15th total of 78,200 shares. Based on an average daily trading volume, of 18,800 […]
Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating) dropped 0.4% during mid-day trading on Tuesday . The stock traded as low as $1.76 and last traded at $1.85. Approximately 8,357 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 765,556 shares. The stock had previously closed at […]
bioAffinity Technologies (NASDAQ:BIAF – Get Rating) and Bioqual (OTCMKTS:BIOQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Earnings & Valuation This table compares bioAffinity Technologies and Bioqual’s […]
bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating)’s stock price was down 1% during mid-day trading on Tuesday . The company traded as low as $2.02 and last traded at $2.03. Approximately 8,182 shares traded hands during trading, a decline of 99% from the average daily volume of 983,699 shares. The stock had previously closed at […]
bioAffinity Technologies (NASDAQ:BIAF – Get Rating) and iSpecimen (NASDAQ:ISPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Profitability This table compares bioAffinity Technologies and iSpecimen’s net margins, […]